CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

About the Chair

Executive Board

Jean-Pierre Després, Scientific Director: Director of Research in Cardiology, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec
Professor, Faculty of Medicine, Université Laval
Québec City, Québec, Canada; See resume

Jean-Claude Coubard, Executive Director: Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec City, Québec, Canada; See resume

Philip Barter: Director, The Heart Research Institute, Sydney, Australia; See resume

H. Bryan Brewer, Jr.: Director, Lipoprotein and Atherosclerosis Research, MedStar Research Institute, Cardiovascular Research Institute, Washington, DC, USA; See resume

Peter Libby: Mallinckrodt Professor of Medecine
Chief, Cardiovascular Medicine, Harvard Medical School
Brigham & Women’s Hospital, Department of Medicine
Boston, MA, USA; See resume

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.